ClinicaliQ Trial Snapshot
- Real World European Investigation of Safety and Clinical Efficacy of the EVOQUE System (TRISCEND III EU) — Recruiting • Cardiology / Cardiovascular • NCT06569602.
- What is being tested: The Edwards EVOQUE system is undergoing real-world safety and clinical efficacy evaluation across multiple European centres in a prospective, single-arm study design.
- Patient eligibility overview: This real-world investigation enrolls patients meeting criteria for the EVOQUE system; specific eligibility parameters would be detailed in the full protocol but typically include patients with appropriate cardiac anatomy and clinical indication for the intervention.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
This is a prospective, single-arm, multi-center, real-world study of an the Edwards EVOQUE system.
Eligibility Snapshot
- : 1. The Local Site Heart Team determines that the patient is appropriate for transcatheter tricuspid valve replacement with the EVOQUE system per the current instructions for use.
- Patient agrees to attend follow-up assessments. 3. Patients provided written informed consent for participation in the study.
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.